ALMR
ALMR
Positions held
Your positionsALMR isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026
2026-10-05 · Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
2026-09-01 · Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
2026-08-18 · Alamar Biosciences (ALMR) Q2 2026 Earnings Call Transcript
2026-08-11 · Sector Update: Healthcare Stocks Softer Late Afternoon
2026-08-11 · Top Midday Gainers
2026-08-11 · BofA Adjusts Price Target on Alamar Biosciences to $31 From $30
2026-08-11 · Alamar Biosciences Inc (ALMR) (Q2 2026) Earnings Call Highlights: Revenue Surges 82% on 147% ...
2026-08-11 · Alamar Biosciences (ALMR) Stock Trades At A Premium To Its Sales
2026-08-10 · Alamar Biosciences Q2 Earnings Call Highlights
2026-08-10 · Alamar: Q2 Earnings Snapshot
Price (daily)
Full chart · RSI · MACD · patterns